Please login to the form below

Not currently logged in
Email:
Password:

anti-infectives

This page shows the latest anti-infectives news and features for those working in and with pharma, biotech and healthcare.

IFPMA launches AMR Action Fund to tackle antimicrobial resistance

IFPMA launches AMR Action Fund to tackle antimicrobial resistance

Pfizer is one of the few large, research-based pharmaceutical companies that are still active in research and development for anti-infectives.

Latest news

More from news
Approximately 4 fully matching, plus 51 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    An immunologist with over two decades’ experience in anti-infectives research and drug development, Deborah set up Novabiotic Pharmaceuticals to discover and develop the next generation of treatments.

  • Deal Watch May 2016 Deal Watch May 2016

    Not only but also…. To close this month a recent report from the UK government expresses concerns about the lack of investment in anti-infectives R&D.

  • Another lost decade for research? Another lost decade for research?

    use but new classes of antibiotics - as well as non-antibiotic approaches such as other anti-infective treatments. ... Over the past 10 years the number of patent families filed in the antibiotics and anti-infectives field has remained stable, with

  • Pharma deals in June 2015 Pharma deals in June 2015

    CNS, diabetes, respiratory, vaccines and anti-infectives, oncology and autoimmune diseases. ... The consequences of acquisitions. One of the consequences of M&A is the need to assess a newly combined portfolio for potential anti-competitive issues.

  • Pharma deals in February 2015 Pharma deals in February 2015

    Hospira's broad generic sterile injectables business covers acute care and oncology which compliments Pfizer's branded sterile injectables covering anti-infectives, anti-inflammatories and cytotoxics.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    Prior to that, McDevitt held positions with increasing responsibility within worldwide business development at GSK Ventures and Anti-Infectives Discovery.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Lavino joins the Austrian clinical-stage biopharma firm from Merck &Co (MSD), bringing nearly two decades of pharmaceutical sales and marketing experience with expertise in anti-infective medications. ... Prior to serving MSD as its acting vice president,

  • Cidara Therapeutics makes senior appointments Cidara Therapeutics makes senior appointments

    Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management. ... Cidara focuses on the discovery, development and

  • Xellia forms scientific advisory board Xellia forms scientific advisory board

    Will further progress on innovative anti-infectives. Xellia Pharmaceuticals, who have a focus on anti-infective treatments, has announced the formation of a new scientific advisory board.

  • Melinta names chief medical officer Melinta names chief medical officer

    She has prior experience in developing anti-infectives, including Cubicin (daptomycin) during her time at Novartis, where she served as VP and global programme head for the company's immunology and ... At Pharmacia, she worked on the anti-infective Zyvox

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • SENIOR PHARMA MARKETER JOINS CELLO HEALTH CONSULTING

    Most recently, Jon was  working at Astellas Europe. He joined the company as Director of Early Phase Commercial Development, before heading up Astellas’ European marketing team for Anti-Infectives.  Prior to

  • SEVEN STONES SEVEN STONES

    Branding. Digital and tech solutions. Exercise co-prescription. Workplace wellbeing. Experience. Anti-infectives, cardiovascular, contrast media, dermatology, diabetes,  diagnostics, gastroenterology, gene therapy, health and fitness,  hepatology,

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics